BSX
Boston Scientific Corporation · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -2.9% · netto nieuwe posities -3.6% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 7.31M | $317.13M | n/a | −3 |
| Q2 2026 | 180 | -1 | 1.05B | $45.33B | +3 | −5 |
| Q1 2026 | 185 | -2 | 1.08B | $67.75B | +2 | −5 |
| Q4 2025 | 186 | +1 | 1.13B | $107.60B | +2 | n/a |
| Q3 2025 | 28 | 0 | 719.46M | $70.18B | n/a | −1 |
| Q2 2025 | 26 | -1 | 668.30M | $71.71B | n/a | −1 |
| Q1 2025 | 24 | +1 | 275.71M | $27.75B | +1 | n/a |
| Q4 2024 | 23 | -1 | 268.54M | $23.93B | n/a | −1 |
| Q3 2024 | 23 | +2 | 200.54M | $16.75B | +2 | n/a |
| Q2 2024 | 21 | n/a | 195.84M | $15.04B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 145.18M | -1.0% | $14.17B | 0.2% | ▼ Trim | 2 | SEC ↗ ×22 |
| 2 | The Vanguard Group ✦ (passief) | 138.25M | +0.8% | $13.50B | 0.2% | ▲ Add | 2 | SEC ↗ ×6 |
| 3 | Fidelity (FMR) ✦ | 99.48M | -8.2% | $9.71B | 0.5% | ▼ Trim | 2 | SEC ↗ ×7 |
| 4 | State Street Global Advisors ✦ (passief) | 64.93M | -0.4% | $6.34B | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 5 | JPMorgan Chase ✦ | 56.66M | n/a | $5.53B | 0.2% | n/c | 1 | SEC ↗ ×42 |
| 6 | PRIMECAP Management ✦ | 33.10M | -4.5% | $3.23B | 2.5% | ▼ Trim | 6 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 32.69M | +0.8% | $3.18B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Capital World Investors ✦ | 26.65M | -6.6% | $2.60B | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 20.71M | n/a | $2.02B | 0.1% | n/c | 1 | SEC ↗ ×22 |
| 10 | Goldman Sachs Group ✦ | 15.01M | n/a | $1.46B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 11 | Wellington Management ✦ | 14.65M | -55.1% | $1.43B | 0.3% | ▼ Trim | 6 | SEC ↗ ×8 |
| 12 | Marshall Wace ✦ | 9.80M | +30.7% | $956.68M | 1.1% | ▲ Add | 6 | SEC ↗ ×3 |
| 13 | D. E. Shaw & Co. ✦ | 8.91M | +31.9% | $869.92M | 0.7% | ▲ Add | 6 | SEC ↗ ×2 |
| 14 | Citadel Advisors ✦ | 8.91M | +64.8% | $869.52M | 0.7% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | Fisher Asset Management ✦ | 8.46M | +9.8% | $826.05M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 8.38M | -24.0% | $817.88M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Arrowstreet Capital ✦ | 8.37M | +28.1% | $816.91M | 0.5% | ▲ Add | 6 | SEC ↗ |
| 18 | Millennium Management ✦ | 8.52M | +83.9% | $783.46M | 0.6% | ▲ Add | 6 | SEC ↗ |
| 19 | Viking Global Investors ✦ | 2.64M | -13.3% | $257.91M | 0.7% | ▼ Trim | 5 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 2.53M | +2.6% | $247.16M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 1.63M | -33.7% | $159.24M | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 1.35M | -34.4% | $131.55M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 1.17M | -36.4% | $114.41M | 0.1% | ▼ Trim | 6 | SEC ↗ ×5 |
| 24 | Renaissance Technologies ✦ | 917.11K | -38.7% | $89.54M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 25 | Gotham Asset Management ✦ | 201.11K | +169.9% | $19.63M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 26 | Bridgewater Associates ✦ | 159.73K | +230.8% | $15.59M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 27 | GAMCO Investors ✦ | 123.99K | -1.0% | $12.11M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 28 | Dodge & Cox ✦ | 88.89K | -1.7% | $8.68M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $2.09B | was 0.3% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,653 houders, 1.31B aandelen, $78.98B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Director · 2.04K aand @ 49.22 · $100,408
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie